Author:
Davidson Nicholas O.,Anant Shrikant
Reference69 articles.
1. Adeli, K., Wettesten, M., Asp, L., Mohammadi, A., Macri, J., and Olofsson, S. O., 1997, Intracellular assembly and degradation of apolipoprotein B-100-containing lipoproteins in digitonin-permeabilized Hep G2 cells, J. Biol. Chem. 272(8):5031–5039.
2. Anant, S., MacGinnitie, A. J., and Davidson, N. O., 1995a, Apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein, J. Biol. Chem. 270(24): 14762–14767.
3. Anant, S., MacGinnitie, A. J., and Davidson, N. O., 1995b, The binding of apobec-1 to mammalian apo B RNA is stabilized by the presence of complementation factors which are required for post-transcriptional editing, Nucleic Acids Symp. Ser 33:99–102.
4. Backus, J. W., and Smith, H. C., 1992, Three distinct RNA sequence elements are required for efficient apolipoprotein B (apo B) RNA editing in vitro, Nucleic Acids Res. 20(22):6007–6014.
5. Benoist, F., and Grand-Perret, T., 1997, Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on Hep G2 cells treated with an inhibitor of microsomal triglyceride transfer protein, J. Biol. Chem. 272(33):20435–20442.